John Mastropaolo

2.2k total citations
66 papers, 1.8k citations indexed

About

John Mastropaolo is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, John Mastropaolo has authored 66 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Cellular and Molecular Neuroscience, 40 papers in Molecular Biology and 7 papers in Psychiatry and Mental health. Recurrent topics in John Mastropaolo's work include Neuroscience and Neuropharmacology Research (40 papers), Receptor Mechanisms and Signaling (19 papers) and Neurotransmitter Receptor Influence on Behavior (16 papers). John Mastropaolo is often cited by papers focused on Neuroscience and Neuropharmacology Research (40 papers), Receptor Mechanisms and Signaling (19 papers) and Neurotransmitter Receptor Influence on Behavior (16 papers). John Mastropaolo collaborates with scholars based in United States and Czechia. John Mastropaolo's co-authors include Stephen I. Deutsch, Richard B. Rosse, Barbara L. Schwartz, John M. Morihisa, Anthony L. Riley, Jacqueline N. Crawley, Peter J. Winsauer, Donald M. Thompson, N. Suzan Nadi and Nancy L. Ostrowski and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biological Psychiatry and Brain Research.

In The Last Decade

John Mastropaolo

66 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Mastropaolo United States 24 1.1k 787 317 285 181 66 1.8k
Kirsten Krebs-Thomson United States 10 1.2k 1.1× 674 0.9× 329 1.0× 222 0.8× 189 1.0× 10 1.8k
Kaori Koike Japan 14 873 0.8× 361 0.5× 443 1.4× 182 0.6× 306 1.7× 22 1.7k
N. Suzan Nadi United States 25 1.2k 1.1× 660 0.8× 248 0.8× 231 0.8× 90 0.5× 37 1.9k
G E Duncan United States 20 1.6k 1.5× 940 1.2× 348 1.1× 479 1.7× 189 1.0× 31 2.5k
Teresa J. Tolliver United States 19 909 0.9× 499 0.6× 179 0.6× 218 0.8× 186 1.0× 25 1.6k
Melissa L. Perreault Canada 22 1.3k 1.2× 978 1.2× 320 1.0× 231 0.8× 155 0.9× 59 2.0k
Serge Gobaille France 25 1.2k 1.1× 561 0.7× 214 0.7× 110 0.4× 129 0.7× 53 1.9k
Pavel I. Ortinski United States 26 1.4k 1.3× 862 1.1× 561 1.8× 307 1.1× 140 0.8× 46 2.4k
Takeshi Izumi Japan 26 893 0.8× 472 0.6× 568 1.8× 232 0.8× 226 1.2× 84 1.8k
Paul B. Hicks United States 20 846 0.8× 561 0.7× 464 1.5× 320 1.1× 126 0.7× 46 1.7k

Countries citing papers authored by John Mastropaolo

Since Specialization
Citations

This map shows the geographic impact of John Mastropaolo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Mastropaolo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Mastropaolo more than expected).

Fields of papers citing papers by John Mastropaolo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Mastropaolo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Mastropaolo. The network helps show where John Mastropaolo may publish in the future.

Co-authorship network of co-authors of John Mastropaolo

This figure shows the co-authorship network connecting the top 25 collaborators of John Mastropaolo. A scholar is included among the top collaborators of John Mastropaolo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Mastropaolo. John Mastropaolo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deutsch, Stephen I., John Mastropaolo, Jessica A. Burket, & Richard B. Rosse. (2009). An epigenetic intervention interacts with genetic strain differences to modulate the stress-induced reduction of flurazepam's antiseizure efficacy in the mouse. European Neuropsychopharmacology. 19(6). 398–401. 9 indexed citations
2.
3.
Deutsch, Stephen I., et al.. (2007). Guanosine possesses specific modulatory effects on NMDA receptor-mediated neurotransmission in intact mice. European Neuropsychopharmacology. 18(4). 299–302. 17 indexed citations
4.
Schwartz, Barbara L., et al.. (2006). Imitation of facial expressions in schizophrenia. Psychiatry Research. 145(2-3). 87–94. 32 indexed citations
5.
6.
Mastropaolo, John, et al.. (2004). Behavioral consequences of methyllycaconitine in mice: a model of α7 nicotinic acetylcholine receptor deficiency. Life Sciences. 74(25). 3133–3139. 22 indexed citations
7.
Deutsch, Stephen I., Barbara L. Schwartz, Richard B. Rosse, et al.. (2003). Adjuvant Topiramate Administration: A Pharmacologic Strategy for Addressing NMDA Receptor Hypofunction in Schizophrenia. Clinical Neuropharmacology. 26(4). 199–206. 29 indexed citations
8.
Deutsch, Stephen I., Richard B. Rosse, Eddie N. Billingslea, Alan S. Bellack, & John Mastropaolo. (2003). Modulation of MK-801-elicited mouse popping behavior by galantamine is complex and dose-dependent. Life Sciences. 73(18). 2355–2361. 15 indexed citations
9.
10.
Deutsch, Stephen I., Richard B. Rosse, Alan S. Bellack, Eddie N. Billingslea, & John Mastropaolo. (2003). Methyllycaconitine Fails to Inhibit Electrically Precipitated Tonic Hindlimb Extension in Mice. Clinical Neuropharmacology. 26(2). 62–64. 2 indexed citations
11.
Deutsch, Stephen I., Richard B. Rosse, Eddie N. Billingslea, Alan S. Bellack, & John Mastropaolo. (2002). Topiramate antagonizes MK-801 in an animal model of schizophrenia. European Journal of Pharmacology. 449(1-2). 121–125. 39 indexed citations
12.
Deutsch, Stephen I., et al.. (1999). Stress and a Glycinergic Intervention Interact in the Modulation of MK-801–Elicited Mouse Popping Behavior. Pharmacology Biochemistry and Behavior. 62(2). 395–398. 6 indexed citations
13.
Deutsch, Stephen I., et al.. (1995). MK-801 alters the GABAA receptor complex and potentiates flurazepam's antiseizure efficacy. Pharmacology Biochemistry and Behavior. 51(4). 909–915. 13 indexed citations
14.
Deutsch, Stephen I. & John Mastropaolo. (1993). Discriminative stimulus properties of midazolam are shared by a GABA-receptor positive steroid. Pharmacology Biochemistry and Behavior. 46(4). 963–965. 19 indexed citations
15.
Mastropaolo, John, et al.. (1992). Glycinergic interventions potentiate the ability of MK 801 to raise the threshold voltage for tonic hindlimb extension in mice. Pharmacology Biochemistry and Behavior. 43(2). 609–612. 16 indexed citations
16.
Mastropaolo, John, et al.. (1992). Reduction of flurazepam's antiseizure efficacy persists after stress. Pharmacology Biochemistry and Behavior. 42(4). 681–684. 5 indexed citations
17.
Rosse, Richard B., et al.. (1991). Subtype diagnosis in schizophrenia and its relation to neuropsychological and computerized tomography measures. Biological Psychiatry. 30(1). 63–72. 26 indexed citations
18.
Mastropaolo, John, et al.. (1989). Conditioned taste aversions as a behavioral baseline for drug discrimination learning: An assessment with phencyclidine. Pharmacology Biochemistry and Behavior. 32(1). 1–8. 49 indexed citations
19.
Deutsch, Stephen I., et al.. (1989). The Role of Excitatory Amino Acids and Intraneuronal Calcium in the Acute Intoxicational Effects of Ethanol. Clinical Neuropharmacology. 12(6). 483–489. 8 indexed citations
20.
Mastropaolo, John & Jacqueline N. Crawley. (1988). Behavioral evidence for increased acetylcholine receptor sensitivity after nucleus basalis magnocellularis lesions in the rat. European Journal of Pharmacology. 153(2-3). 301–304. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kirsten Krebs-Thomson Breakdown of academic impact, for papers by Kaori Koike Breakdown of academic impact, for papers by N. Suzan Nadi Breakdown of academic impact, for papers by G E Duncan Breakdown of academic impact, for papers by Teresa J. Tolliver Breakdown of academic impact, for papers by Melissa L. Perreault Breakdown of academic impact, for papers by Serge Gobaille Breakdown of academic impact, for papers by Pavel I. Ortinski Breakdown of academic impact, for papers by Takeshi Izumi Breakdown of academic impact, for papers by Paul B. Hicks
Rankless by CCL
2026